Literature DB >> 23723017

Very well-differentiated gastric carcinoma of intestinal type: analysis of diagnostic criteria.

Tetsuo Ushiku1, Thomas Arnason, Shinichi Ban, Tsunekazu Hishima, Michio Shimizu, Masashi Fukayama, Gregory Y Lauwers.   

Abstract

Very well-differentiated gastric adenocarcinoma of intestinal type is a rare variant of gastric cancer characterized by low-grade nuclear atypia, and for which the diagnostic criteria and clinical behavior are not fully established. This study presents a detailed histologic, immunohistochemical, and clinical analysis of 21 cases. Nuclear atypia was mild in all cases. Characteristic architectural features of this gastric adenocarcinoma variant were pit and glandular anastomosis, spiky glands, distended glands, discohesive cells, abortive glands, and glandular outgrowth. At least three of these features were present in all the cases. Retrospective review of preoperative biopsies in 18 patients revealed that half of the biopsies were originally reported as negative or indeterminate for malignancy. On the basis of immunohistochemical stains for intestinal (MUC2, CD10, and CDX-2) and gastric (MUC5AC and MUC6) markers, 11 (52%) cases had an intestinal immunophenotype and 10 (48%) cases had a mixed immunophenotype. Foci of discohesive neoplastic cells, indicating dedifferentiation toward a poorly cohesive carcinoma, were observed exclusively in neoplasms of mixed immunophenotype (n=5). All patients with follow-up but one were alive without disease at a mean of 19 months (range 1-60 months). One individual with a pT4 tumor with associated poorly cohesive carcinoma died of disease. In summary, very well-differentiated gastric adenocarcinomas are diagnostically challenging. Architectural features are critical to making the diagnosis. Cases with pure intestinal immunophenotype have not been associated with transformation into poorly cohesive carcinoma, and appear to behave as biologically low grade. Those with mixed immunophenotype appear more likely to dedifferentiate and behave more aggressively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23723017     DOI: 10.1038/modpathol.2013.98

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.

Authors:  Chihiro Minatsuki; Nobutake Yamamichi; Ken-Ichi Inada; Yu Takahashi; Kouhei Sakurai; Takeshi Shimamoto; Yosuke Tsuji; Kazuya Shiogama; Shinya Kodashima; Yoshiki Sakaguchi; Keiko Niimi; Satoshi Ono; Toru Niwa; Ken Ohata; Nobuyuki Matsuhashi; Masao Ichinose; Mitsuhiro Fujishiro; Yutaka Tsutsumi; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2018-06-28       Impact factor: 3.199

2.  Distinct expression profile of key molecules in crawling-type early gastric carcinoma.

Authors:  Ha Young Woo; Yoon Sung Bae; Jie-Hyun Kim; Sang Kil Lee; Yong Chan Lee; Jae-Ho Cheong; Sung Hoon Noh; Hyunki Kim
Journal:  Gastric Cancer       Date:  2016-10-12       Impact factor: 7.370

3.  Risk factors for under-diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients.

Authors:  Guifang Xu; Weijie Zhang; Ying Lv; Bin Zhang; Qi Sun; Tingsheng Ling; Xiaoqi Zhang; Zhihua Zhou; Lei Wang; Qin Huang; Xiaoping Zou
Journal:  Surg Endosc       Date:  2015-09-30       Impact factor: 4.584

4.  Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer.

Authors:  Jun Hee Lee; Jun Haeng Lee; Kyoung-Mee Kim; Ki Joo Kang; Byung-Hoon Min; Jae J Kim
Journal:  Surg Endosc       Date:  2015-02-12       Impact factor: 4.584

5.  Novel Pathologic Factors for Risk Stratification of Gastric "Indefinite for Dysplasia" Lesions.

Authors:  Kwangil Yim; Jung Ha Shin; Jinyoung Yoo
Journal:  Gastroenterol Res Pract       Date:  2020-09-29       Impact factor: 2.260

Review 6.  Clinicopathology of Early Gastric Carcinoma: An Update for Pathologists and Gastroenterologists.

Authors:  Qin Huang; Xiaoping Zou
Journal:  Gastrointest Tumors       Date:  2017-02-11

7.  Gastric-Type Extremely Well-Differentiated Adenocarcinoma of the Stomach: A Challenge for Preoperative Diagnosis.

Authors:  Mee Joo; Song Hee Han
Journal:  J Pathol Transl Med       Date:  2015-09-30

8.  Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients.

Authors:  Chiko Sato; Kingo Hirasawa; Yoko Tateishi; Yuichiro Ozeki; Atsushi Sawada; Ryosuke Ikeda; Takehide Fukuchi; Masafumi Nishio; Ryosuke Kobayashi; Makomo Makazu; Hiroaki Kaneko; Yoshiaki Inayama; Shin Maeda
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

9.  Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma.

Authors:  Yasuko Fujita; Noriyuki Uesugi; Ryo Sugimoto; Makoto Eizuka; Yosuke Toya; Risaburo Akasaka; Takayuki Matsumoto; Tamotsu Sugai
Journal:  Diagn Pathol       Date:  2020-09-17       Impact factor: 2.644

10.  Treatment for gastric 'indefinite for neoplasm/dysplasia' lesions based on predictive factors.

Authors:  Mi Jung Kwon; Ho Suk Kang; Hyeon Tae Kim; Jin Woo Choo; Bo Hyun Lee; Sung Eun Hong; Kun Ha Park; Dong Min Jung; Hyun Lim; Jae Seung Soh; Sung Hoon Moon; Jong Hyeok Kim; Hye-Rim Park; Soo Kee Min; Jin Won Seo; Ji-Young Choe
Journal:  World J Gastroenterol       Date:  2019-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.